Geode Capital Management, LLC Nu Cana PLC Transaction History

Geode Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.76 - $1.69 $4,779 - $10,628	6,289 Added 50.37%	18,775 $18,000
Q1 2022 May 13, 2022	BUY	$0.74 - $3.27 $9,239 - $40,829	12,486 New	12,486 $12,000
Q3 2021 Nov 12, 2021	SELL	$1.95 - $2.85 $28,271 - $41,319	-14,498 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$4.38 - $7.0 $63,501 - $101,486	14,498 New	14,498 $72,000
Q4 2020 Feb 12, 2021	SELL	$4.4 - $5.59 $126,746 - $161,025	-28,806 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$4.57 - $6.48 $11,031 - $15,642	2,414 Added 9.15%	28,806 $148,000
Q2 2020 Aug 13, 2020	BUY	$4.87 - $7.37 $53,506 - $80,974	10,987 Added 71.32%	26,392 $142,000
Q1 2020 May 14, 2020	BUY	$4.02 - $9.05 $12,096 - $27,231	3,009 Added 24.27%	15,405 $89,000
Q4 2019 Feb 13, 2020	BUY	$5.55 - $8.48 $68,797 - $105,118	12,396 New	12,396 $75,000

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $59M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.